AB vs. XBI
AB (AllianceBernstein Holding L.P.) is a stock, while XBI (SPDR S&P Biotech ETF) is Health & Biotech Equities fund tracking the S&P Biotechnology Select Industry Index. Over the past 10 years, AB returned 14.02%/yr vs 11.35%/yr for XBI. At a 0.37 correlation, their price movements are largely independent.
Performance
AB vs. XBI - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, AB achieves a -4.44% return, which is significantly lower than XBI's 22.90% return. Over the past 10 years, AB has outperformed XBI with an annualized return of 14.02%, while XBI has yielded a comparatively lower 11.35% annualized return.
AB
- 1D
- -1.73%
- 1M
- -7.30%
- YTD
- -4.44%
- 6M
- -5.76%
- 1Y
- -5.19%
- 3Y*
- 12.89%
- 5Y*
- 3.04%
- 10Y*
- 14.02%
XBI
- 1D
- 1.82%
- 1M
- 13.82%
- YTD
- 22.90%
- 6M
- 18.65%
- 1Y
- 79.43%
- 3Y*
- 20.96%
- 5Y*
- 1.67%
- 10Y*
- 11.35%
AB vs. XBI - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
AB AllianceBernstein Holding L.P. | -4.44% | 13.36% | 30.40% | -2.29% | -23.46% | 56.27% | 23.00% | 19.85% | 21.04% | 16.76% |
XBI SPDR S&P Biotech ETF | 22.90% | 35.89% | 1.01% | 7.60% | -25.87% | -20.45% | 48.33% | 32.56% | -15.28% | 43.77% |
Correlation
The correlation between AB and XBI is 0.13, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.13 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.27 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.35 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.33 |
Correlation (All Time) Calculated using the full available price history since Feb 6, 2006 | 0.37 |
Over the past year, the correlation between AB and XBI has dropped to 0.13 - well below their long-term average of 0.37, suggesting their price drivers have been diverging.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
AB vs. XBI — Risk / Return Rank
AB
XBI
AB vs. XBI - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for AllianceBernstein Holding L.P. (AB) and SPDR S&P Biotech ETF (XBI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| AB | XBI | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -3.25 | ||
| Sortino ratioReturn per unit of downside risk | -4.07 | ||
| Omega ratioGain probability vs. loss probability | 0.98 | 1.47 | -0.49 |
| Calmar ratioReturn relative to maximum drawdown | -0.36 | 8.21 | -8.57 |
| Martin ratioReturn relative to average drawdown | -0.73 | 24.27 | -25.00 |
Loading charts...
Drawdowns
AB vs. XBI - Drawdown Comparison
The maximum AB drawdown since its inception was -87.65%, which is greater than XBI's maximum drawdown of -63.89%. Use the drawdown chart below to compare losses from any high point for AB and XBI.
Loading charts...
Drawdown Indicators
| AB | XBI | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -87.65% | -63.89% | -23.76% |
Max Drawdown (1Y)Largest decline over 1 year | -14.68% | -9.72% | -4.96% |
Max Drawdown (3Y)Largest decline over 3 years | -20.59% | -32.99% | +12.40% |
Max Drawdown (5Y)Largest decline over 5 years | -45.76% | -54.71% | +8.95% |
Max Drawdown (10Y)Largest decline over 10 years | -58.08% | -63.89% | +5.81% |
Current DrawdownCurrent decline from peak | -14.08% | -13.39% | -0.69% |
Average DrawdownAverage peak-to-trough decline | -26.19% | -20.93% | -5.26% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 7.09% | 3.28% | +3.81% |
Volatility
AB vs. XBI - Volatility Comparison
The current volatility for AllianceBernstein Holding L.P. (AB) is 3.96%, while SPDR S&P Biotech ETF (XBI) has a volatility of 9.94%. This indicates that AB experiences smaller price fluctuations and is considered to be less risky than XBI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| AB | XBI | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 3.96% | 9.94% | -5.98% |
Volatility (6M)Calculated over the trailing 6-month period | 17.96% | 21.21% | -3.25% |
Volatility (1Y)Calculated over the trailing 1-year period | 22.33% | 26.52% | -4.19% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 28.20% | 32.29% | -4.09% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 32.38% | 32.00% | +0.38% |
Dividends
AB vs. XBI - Dividend Comparison
AB's dividend yield for the trailing twelve months is around 9.70%, more than XBI's 0.38% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
AB AllianceBernstein Holding L.P. | 9.70% | 9.02% | 8.03% | 8.44% | 10.30% | 7.33% | 8.26% | 7.67% | 10.54% | 8.50% | 7.46% | 8.09% |
XBI SPDR S&P Biotech ETF | 0.38% | 0.37% | 0.15% | 0.02% | 0.00% | 0.04% | 0.20% | 0.00% | 0.28% | 0.24% | 0.26% | 0.61% |
Frequently Asked Questions
AB and XBI have a correlation of 0.13, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
XBI has higher volatility (9.94%) compared to AB (3.96%). In terms of maximum drawdown, AB dropped -87.65% vs XBI's -63.89%.
XBI currently has the higher Sharpe Ratio (3.02 vs -0.23), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for AB and XBI
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer